News | May 05, 2022
JBCPL emerges as the fastest growing pharma company: Report
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
Demand for pharmacies contribute to 52% of the total searches, vaccination centres 30%
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
The report has estimated 4.74 million deaths for India in 2020 and 2021,
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Subscribe To Our Newsletter & Stay Updated
